|
May 9
|
Accuray Third Quarter 2025 Earnings: Beats Expectations
|
|
May 7
|
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
|
|
Jan 27
|
With 61% ownership, Accuray Incorporated (NASDAQ:ARAY) boasts of strong institutional backing
|